AML Insights – June Update: What’s New in the Field
Discover the key developments in the treatment of acute myeloid leukemia, including advances in CAR-T cell and NK cell therapies, new combination regimens such as venetoclax with hypomethylating agents, and targeted chemotherapy using anti-CD33 antibodies.
Don’t miss these exciting developments!
Relateret indhold
Brænder du for at skrive?
Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk
Send mail til redaktionen